> ## Content Index
> Fetch the complete content index at: https://www.bullished.co/llms.txt
> Use this file to discover other available public pages before exploring further.

# Kimberly-Clark Closes Kenvue Deal: 0.14625 Shares Plus $3.50 Cash For Each Kenvue Share
- URL: https://www.bullished.co/kimberly-clark-closes-kenvue-deal-0-14625-shares-plus-3-50-cash-for-each-kenvue-share-db9b6700/
- Published: 2026-11-02T14:35:59.000Z
- Updated: 2026-11-02T14:35:59.000Z
- Description: Kenvue becomes a wholly owned Kimberly-Clark unit called Kenvue LLC, with NYSE delisting and an end to SEC reporting to follow.
- Author: Matteo Parrino
- Tags: SEC Filings, KVUE, Industry: Consumer Staples

Kimberly-Clark closed its takeover of [Kenvue](https://www.bullished.co/tag/kvue/) on Monday, converting each Kenvue share into [0.14625 Kimberly-Clark shares plus $3.50 in cash](https://www.sec.gov/Archives/edgar/data/0001944048/000095015726001147/form8-k.htm?ref=bullished.co), according to an [8-K](https://www.bullished.co/learn/8-k-items-explained/) the company filed. Kenvue, the maker of Tylenol, Neutrogena and Listerine, is now a wholly owned subsidiary renamed Kenvue LLC.

## Shares, cash and a new name

Holders who owned Kenvue stock at closing now have only the right to receive that consideration. Cash replaces any fractional Kimberly-Clark share. Kenvue stock options, restricted stock units and deferred stock units converted into equivalent Kimberly-Clark awards. Performance stock units became solely time-vesting restricted stock units.

Kimberly-Clark paid the cash portion from cash on hand, debt financing and proceeds of its previously announced sale of a 51% interest in its International Family Care and Professional business.

The deal ran as two mergers: a Kimberly-Clark subsidiary merged into Kenvue, which then merged into a second subsidiary. That second step left a member-managed limited liability company, [Kenvue LLC](https://www.sec.gov/Archives/edgar/data/0001944048/000095015726001147/ex3-1.htm?ref=bullished.co).

## Delisting and a clean-out of the boardroom

Kenvue asked the New York Stock Exchange to suspend trading before Monday's open and to file a Form 25, the application to delist the shares. The delisting takes effect 10 days after that filing. The surviving company then intends to file a Form 15 to deregister the shares and end Kenvue's SEC reporting obligations.

All 12 directors resigned at the first merger's effective time: Larry Merlo, Richard E. Allison, Jr., Seemantini Godbole, Melanie L. Healey, Sarah Hofstetter, Betsy D. Holden, Erica Mann, Kathleen Pawlus, Kirk Perry, Vasant Prabhu, Jeff Smith and Michael E. Sneed. Nelson Urdaneta, Kenvue LLC's president and CEO, signed the filing.

## Debt moves to Kenvue LLC

Kenvue repaid and terminated its five-year, $4.0 billion revolving credit facility, which had no borrowings outstanding at closing. It also ended its long-term incentive plan and its deferred fee plan for directors.

Kenvue LLC assumed seven series of senior notes under a Fourth Supplemental Indenture dated November 2, 2026:

- $1.0 billion of 5.050% notes due 2028.
- $1.0 billion of 5.000% notes due 2030.
- $750 million of 4.850% notes due 2032.
- $1.25 billion of 4.900% notes due 2033.
- $750 million of 5.100% notes due 2043.
- $1.5 billion of 5.050% notes due 2053.
- $750 million of 5.200% notes due 2063.

## An $8 million cap for the general counsel

On Sunday, a Kenvue subsidiary agreed to cover any excise tax General Counsel Matthew Orlando incurs on merger-related payments, so he ends up in the same after-tax position. The payments cannot exceed $8 million, though they are expected to be substantially less.

Kenvue said it gave him the agreement because of his "extraordinary efforts" over the prior year to negotiate and complete the deal. It said he was the only executive expected to stay subject to the tax rule after mitigation steps.

Kenvue's 8-K says the Form 15 follows once the delisting takes effect, ending the company's public filings.

Learn

- [Item 5.01: changes in control of the registrant →](https://www.bullished.co/learn/8-k-items-explained/#item-501-changes-in-control-of-the-registrant)  
From 8-K Items Explained: What Every Item Code From 1.01 To 9.01 Tells You, With Examples

### Sources

- [8-K Filing — Kenvue Inc. (KVUE)](https://www.sec.gov/Archives/edgar/data/0001944048/000095015726001147/form8-k.htm?ref=bullished.co) — SEC EDGAR
- [Exhibit ex3-1.htm — Kenvue Inc. 8-K exhibit](https://www.sec.gov/Archives/edgar/data/0001944048/000095015726001147/ex3-1.htm?ref=bullished.co) — SEC EDGAR

### More on Kenvue

- [Kenvue Ties Feminine-Care Sales And Bond Covenant Removal To Kimberly-Clark Deal Closing](https://www.bullished.co/kenvue-ties-feminine-care-sales-and-bond-covenant-removal-to-kimberly-clark-deal-closing-1ac9575a/)
- [Kenvue Sales Rise 3.2% For A Fourth Straight Quarter, But No Guidance Or Call Ahead Of Kimberly-Clark Deal](https://www.bullished.co/kenvue-sales-rise-3-2-for-a-fourth-straight-quarter-but-no-guidance-or-call-ahead-of-b260e925/)
- [Kenvue Bondholders Back Stripping Covenants From All Seven Note Series, $7 Billion In Total](https://www.bullished.co/kenvue-bondholders-back-stripping-covenants-from-all-seven-note-series-7-billion-in-total-bc1147c3/)

[All Kenvue (KVUE) coverage →](https://www.bullished.co/tag/kvue/)